financetom
Business
financetom
/
Business
/
OpenAI unveils 'o3' reasoning AI models in test phase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI unveils 'o3' reasoning AI models in test phase
Dec 20, 2024 12:23 PM

Dec 20 (Reuters) - OpenAI said on Friday it was testing

new reasoning AI models, o3 and o3 mini, in a sign of growing

competition with rivals such as Google to create smarter models

capable of tackling complex problems.

CEO Sam Altman said the AI startup plans to launch o3 mini

by the end of January, and full o3 after that, as more robust

large language models could outperform existing models and

attract new investments and users.

Microsoft ( MSFT )-backed OpenAI released o1 AI models in

September designed to spend more time processing queries to

solve hard problems.

The o1 models are capable of reasoning through complex tasks

and can solve more challenging problems than previous models in

science, coding and math, the AI firm had said in a blog post.

OpenAI's new o3 and o3 mini models, which are in internal

safety testing currently, will be more powerful than its

previously launched o1 models, the company said.

The GenAI pioneer said it was opening up an application

process for external researchers to test o3 models ahead of the

public release, which will close on Jan. 10.

OpenAI had triggered an AI arms race after it launched

ChatGPT in November 2022. The growing popularity of the company

and new product launches helped OpenAI in closing a $6.6 billion

funding round in October.

Rival Alphabet's Google released the second

generation of its AI model Gemini earlier in December, as the

search giant aims to reclaim the lead in the AI technology race.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients
Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients
Apr 7, 2025
Amneal Pharmaceuticals, Inc. ( AMRX ) revealed a new analysis of the pivotal RISE-PD Phase 3 study on Monday. The data showed that patients who converted to Crexont from immediate release (IR) carbidopa/levodopa (CD/LD) experienced improved sleep quality. These improvements were measured by their Parkinson’s Disease Sleep Scale-2 (PDSS-2) total scores, showing a mean difference of -2.35 (p ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
--Mesa Laboratories Keeps Quarterly Dividend of $0.16, Payable June 16 to Holders of Record May 30
--Mesa Laboratories Keeps Quarterly Dividend of $0.16, Payable June 16 to Holders of Record May 30
Apr 7, 2025
03:16 PM EDT, 04/07/2025 (MT Newswires) -- Price: 108.29, Change: +0.29, Percent Change: +0.27 ...
Strategy Reports $5.91 Billion Unrealized Loss on Digital Assets in Q1
Strategy Reports $5.91 Billion Unrealized Loss on Digital Assets in Q1
Apr 7, 2025
03:15 PM EDT, 04/07/2025 (MT Newswires) -- Strategy (MSTR) on Monday reported $5.91 billion in unrealized loss on its digital holdings for the quarter ending March 31, likely resulting in a net loss despite a $1.69 billion income tax benefit. The loss stems from the company's adoption of Accounting Standards Update No. 2023-08, effective Jan. 1, which requires changes in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved